1. Home
  2. RRGB vs ADAG Comparison

RRGB vs ADAG Comparison

Compare RRGB & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RRGB

Red Robin Gourmet Burgers Inc.

HOLD

Current Price

$5.09

Market Cap

84.4M

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.97

Market Cap

254.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRGB
ADAG
Founded
1969
2011
Country
United States
China
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.4M
254.4M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
RRGB
ADAG
Price
$5.09
$3.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$9.00
$8.25
AVG Volume (30 Days)
467.5K
106.7K
Earning Date
05-28-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
73.43
N/A
EPS
N/A
N/A
Revenue
$1,315,014,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.46
$1.44
52 Week High
$7.52
$4.75

Technical Indicators

Market Signals
Indicator
RRGB
ADAG
Relative Strength Index (RSI) 74.15 58.69
Support Level $3.84 $3.16
Resistance Level $5.29 $3.99
Average True Range (ATR) 0.40 0.35
MACD 0.11 0.05
Stochastic Oscillator 93.06 70.94

Price Performance

Historical Comparison
RRGB
ADAG

About RRGB Red Robin Gourmet Burgers Inc.

Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. The company's brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. It has one operating and one reportable segment: restaurants.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: